Contact Us
Drug Search Results
More Filters [+]

Enoxolone

Alternative Names: enoxolone
Latest Update: 2024-05-13
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: 15-PGDH Inhibitor,PR2 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bosnia | Chile | China | France | Hong Kong | Korea | Lebanon | Morocco | Russia | Spain | Taiwan | Turkey | United Arab Emirates | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Pierre Fabre Laboratories
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Enoxolone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Inflammation

Phase 2: Depressive Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
MNS_02.1

P2

Recruiting

Depressive Disorder

2025-03-01

Enoxolone

N/A

Completed

Chronic Pain|Chronic Periodontitis|Oral Ulcer|Dental Plaque|Periodontal Pocket|Gingivitis

2022-06-01

2008-000990-39

P3

Completed

Inflammation

2009-12-12

Recent News Events

Date

Type

Title

05/13/2024

PubMed

 Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors.

05/10/2024

PubMed

 Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance.

04/29/2024

PubMed

 Application of 18beta-glycyrrhetinic acid in the structural modification of natural products: a review.

05/20/2020

News Article

 BGG Announces GMP+ Certification for its Licorice Production Facility

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions